Back to results
US 2013/0280212 A1Published application
Inhibitors of cytochrome p450
AssigneeGilead Sciences, Inc.
InventorsManoj C. Desai, Hongtao Liu, Lianhong Xu, Hong Ye
Life of this patent
Estimating the term…
Abstract
The present application provides for a compound of formula (I), or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods that include the administration of such compounds with at least one additional therapeutic agent.
Claims30
A compound of formula I:
- wherein:
- A1 is (C1-C6)alkyl, aryl(C1-C6)alkyl, heteroaryl(C1-C6)alkyl, (C3-C6)carbocyclyl(C1-C6)alkyl or heterocyclyl(C1-C6)alkyl, wherein any (C1-C6)alkyl of A1 is optionally substituted with one or more Z1 groups and wherein any aryl(C1-C6)alkyl, heteroaryl(C1-C6)alkyl, (C3-C6)carbocyclyl(C1-C6)alkyl or heterocyclyl(C1-C6)alkyl of A1 is optionally substituted with one or more Z2 groups;
- A2 is (C1-C6)alkyl, aryl(C1-C6)alkyl, heteroaryl(C1-C6)alkyl, (C3-C6)carbocyclyl(C1-C6)alkyl or heterocyclyl(C1-C6)alkyl, wherein any (C1-C6)alkyl of A2 is optionally substituted with one or more Z1 groups and wherein any aryl(C1-C6)alkyl, heteroaryl(C1-C6)alkyl, (C3-C6)carbocyclyl(C1-C6)alkyl or heterocyclyl(C1-C6)alkyl of A2 is optionally substituted with one or more Z2 groups;
- X is selected from the group consisting of R1aOC(O)—, R1bC(O)—, R1a(Ra)NC(O)—, R1bS(O)2— and R1a(Ra)NS(O)2—;
- Y is —C(O)O— or —C(O)NRb—;
- R1a is (C1-C8)alkyl, (C3-C6)carbocyclyl, aryl or aryl(C1-C6)alkyl, wherein any (C1-C8)alkyl of R1a is optionally substituted with one or more Z3 groups and wherein any (C3-C6)carbocyclyl, aryl or aryl(C1-C6)alkyl of R1a is optionally substituted with one or more Z4 groups;
- R1b is (C1-C8)alkyl, (C3-C6)carbocyclyl, aryl, aryl(C1-C6)alkyl, heteroaryl, heteroaryl(C1-C6)alkyl, heterocyclyl or heterocyclyl(C1-C6)alkyl, wherein any (C1-C8)alkyl of R1b is optionally substituted with one or more Z3 groups and wherein any (C3-C6)carbocyclyl, aryl, aryl(C1-C6)alkyl, heteroaryl, heteroaryl(C1-C6)alkyl, heterocyclyl or heterocyclyl(C1-C6)alkyl of R1b is optionally substituted with one or more Z4 groups;
- R2 is selected from the group consisting of H, (C1-C6)alkyl, (C3-C6)carbocyclyl, (C3-C6)carbocyclyl(C1-C6)alkyl- and aryl(C1-C6)alkyl;
- R3 is selected from the group consisting of H, (C1-C6)alkyl, (C3-C6)carbocyclyl, C3-C6)carbocyclyl(C1-C6)alkyl- and aryl(C1-C6)alkyl;
- R4 is aryl, aryl(C1-C6)alkyl, heteroaryl, heteroaryl(C1-C6)alkyl, heterocyclyl or heterocyclyl(C1-C6)alkyl, wherein any aryl, aryl(C1-C6)alkyl, heteroaryl, heteroaryl(C1-C6)alkyl, heterocyclyl or heterocyclyl(C1-C6)alkyl of R4 is optionally substituted with one or more Z5 groups;
- each Z1 is independently selected from OH, oxo, halogen, OCF3, CN, —O(C1-C6)alkyl, S(C1-C6)alkyl, SO(C1-C6)alkyl, S(O)2(C1-C6)alkyl, —NRcRd, —NRiC(O)Rj and —NRiS(O)2Rj;
- each Z2 is independently selected from OH, oxo, halogen, CF3, OCF3, NO2, CN, (C1-C6)alkyl, —O(C1-C6)alkyl, S(C1-C6)alkyl, SO(C1-C6)alkyl, S(O)2(C1-C6)alkyl, —NRcRd, —NRiC(O)Rj and —NRiS(O)2Rj;
- each Z3 is independently selected from OH, halogen, CN, —O(C1-C6)alkyl, and —NReRf;
- each Z4 is independently selected from OH, halogen, CF3, OCF3, NO2, CN, (C1-C6)alkyl, —O(C1-C6)alkyl, aryl and —NReRf, wherein any aryl of Z4 is optionally substituted with one or more (e.g. 1, 2, 3, 4 or 5) groups selected from OH, halogen, —CF3, —OCF3, NO2, CN, (C1-C6)alkyl and —O(C1-C6)alkyl;
- each Z5 is independently selected from OH, oxo, halogen, CF3, OCF3, NO2, CN, (C1-C6)alkyl, —O(C1-C6)alkyl, and —NRgRh;
- Ra is selected from the group consisting of H, (C1-C6)alkyl and aryl(C1-C6)alkyl;
- Rb is selected from the group consisting of H, (C1-C6)alkyl and aryl(C1-C6)alkyl;
- Rc and Rd are each independently selected from H and (C1-C6)alkyl;
- or Rc and Rd together with the nitrogen to which they are attached form a piperidine, morpholine, piperazine, N-methylpiperazine or pyrrolidine;
- Re and Rf are each independently selected from H and (C1-C6)alkyl;
- or Re and Rf together with the nitrogen to which they are attached form a piperidine, morpholine, piperazine, N-methylpiperazine or pyrrolidine;
- and
- Rg and Rh are each independently selected from H and (C1-C6)alkyl;
- or Rg and Rh together with the nitrogen to which they are attached form a piperidine, morpholine, piperazine, N-methylpiperazine or pyrrolidine;
- Ri is H or (C1-C6)alkyl;
- and
- Rj is (C1-C6)alkyl;
- or a salt thereof.
25 more elements
Dependencies are inferred from the claim text.